Exousia Bio (LMMY) Current Assets (2022 - 2024)

Exousia Bio has disclosed Current Assets across 3 years of filings, most recently posting $17717.0 for Q4 2024.

• Current Assets for Q4 2024 came in at $17717.0, up 261.35% year-over-year; the trailing twelve-month figure through Nov 2024 was $17717.0 (up 261.35% YoY), and the FY2024 annual result was $12964.0, up 65.04% from the prior year.
• Current Assets came in at $17717.0 for Q4 2024 at Exousia Bio, up from $17145.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $17717.0 in Q4 2024 to a low of $1318.0 in Q3 2023.
• The 3-year median for Current Assets is $8778.0 (2024), against an average of $9439.0.
• Across the five-year window, Current Assets slipped 22.28% in 2023 and surged 1200.83% in 2024, its largest moves.
• Exousia Bio's Current Assets stood at $10107.0 in 2022, then sank by 51.49% to $4903.0 in 2023, then surged by 261.35% to $17717.0 in 2024.
• The last three Current Assets figures came in at $17717.0 (Q4 2024), $17145.0 (Q3 2024), and $12964.0 (Q2 2024), per Business Quant data.